FPUKX
Price
$26.96
Change
-$0.08 (-0.30%)
Updated
Oct 7 closing price
Net Assets
32.02B
RLBAX
Price
$38.56
Change
-$0.09 (-0.23%)
Updated
Oct 7 closing price
Net Assets
266.1B
Interact to see
Advertisement

FPUKX vs RLBAX

Header iconFPUKX vs RLBAX Comparison
Open Charts FPUKX vs RLBAXBanner chart's image
Fidelity Puritan K
Price$26.96
Change-$0.08 (-0.30%)
VolumeN/A
Net Assets32.02B
American Funds American Balanced R1
Price$38.56
Change-$0.09 (-0.23%)
VolumeN/A
Net Assets266.1B
FPUKX vs RLBAX Comparison Chart in %
View a ticker or compare two or three
VS
FPUKX vs. RLBAX commentary
Oct 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FPUKX is a Buy and RLBAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBAX has more cash in the bank: 266B vs. FPUKX (32B). FPUKX pays higher dividends than RLBAX: FPUKX (1.56) vs RLBAX (1.10). FPUKX was incepted earlier than RLBAX: FPUKX (17 years) vs RLBAX (23 years). RLBAX (1.31) is less costly to investors than FPUKX (0.40). FPUKX is a more actively managed with annual turnover of: 55.00 vs. RLBAX (44.00). FPUKX has a lower initial minimum investment than RLBAX: FPUKX (0) vs RLBAX (250). RLBAX annual gain was more profitable for investors over the last year : 9.12 vs. FPUKX (2.86). RLBAX return over 5 years is better than : 38.04 vs. FPUKX (13.68).
FPUKXRLBAXFPUKX / RLBAX
Total Expense Ratio0.401.3131%
Annual Report Gross Expense Ratio0.401.3131%
Fund Existence17 years23 years-
Gain YTD9.94213.77072%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets32B266B12%
Annual Yield % from dividends1.561.10142%
Returns for 1 year2.869.1231%
Returns for 3 years32.8247.9868%
Returns for 5 years13.6838.0436%
Returns for 10 years51.1468.7274%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
WLY38.330.03
+0.09%
John Wiley & Sons
ROIV16.12-0.14
-0.86%
Roivant Sciences Ltd
PRLD1.44-0.02
-1.37%
Prelude Therapeutics
IVP0.98-0.03
-3.18%
Inspire Veterinary Partners Inc
GRRR19.99-0.68
-3.29%
Gorilla Technology Group